Working with the natural strength of the body's immune system, immunotherapy has the potential to change the way ALL cancers are treated & cured.
Provide guidance and encouragement to others going through their journey with cancer immunotherapy treatment.
Share Your Story
Create a profile and fill out a questionnaire to identify immunotherapy clinical trials you may be eligible for.
CALLING HOURS | M-F 8:30 a.m. to 6 p.m. ET
Se habla espanol
Request a call from a Clinical Trial Navigator
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Nivolumab (Opdivo®) is now available for patients with metastatic and treatment-resistant small cell lung cancer
Gloria Garcia was diagnosed in 2017 with small cell lung cancer. After combination ipilimumab/nivolumab immunotherapy treatment she went into remission.